Quick answer
Madrigal Pharmaceuticals, Inc. (MDGL) reported diluted EPS of $-1.99 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-30. Its last four 10-Q/10-K filings were on 2026-07-30, 2026-05-06, 2026-02-19, 2025-11-04.
Data as of 2026-07-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-07-30 | $-1.99 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-06 | $-3.25 |
| 2025-12-31 | Full year | 10-K | 2026-02-19 | $-12.85 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-04 | $-5.08 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-05 | $-1.90 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-01 | $-3.32 |
| 2024-12-31 | Full year | 10-K | 2025-02-26 | $-21.90 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $-4.92 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-07 | $-7.10 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-07 | $-7.38 |
| 2023-12-31 | Full year | 10-K | 2024-02-28 | $-19.99 |
| 2023-12-31 | Quarter | 10-K | 2024-02-28 | $-5.68 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-06 | $-5.34 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-08 | $-4.69 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-09 | $-4.23 |
| 2022-12-31 | Full year | 10-K | 2023-02-23 | $-17.23 |
Related
- MCK earnings report dates and EPS history (McKESSON CORPORATION)
- MCO earnings report dates and EPS history (Moody'S Corporation)
- MDB earnings report dates and EPS history (Mongodb, Inc.)
- MDLZ earnings report dates and EPS history (Mondelez International, Inc.)
- MDT earnings report dates and EPS history (Medtronic plc)
- MEDP earnings report dates and EPS history (Medpace Holdings, Inc.)
- MELI earnings report dates and EPS history (MercadoLibre, Inc.)
- MET earnings report dates and EPS history (MetLife, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.